SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹48 Cr | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹54 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹54 Cr |
How is Deferred Tax Assets / Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹48 Cr | 12.38 | |
| Mar2024 | ₹43 Cr | 4.34 | |
| Mar2023 | ₹41 Cr | 3.71 | |
| Mar2022 | ₹40 Cr | -26.56 | |
| Mar2021 | ₹54 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,449.1 Cr | 3.8% | -5.3% | 63.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | 3.8% |
-5.3% |
63.2% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses